Edition:
United States

People: GlaxoSmithKline PLC (GSK.L)

GSK.L on London Stock Exchange

1,653.00GBp
23 Sep 2016
Change (% chg)

4.00p (+0.24%)
Prev Close
1,649.00p
Open
1,649.50p
Day's High
1,654.50p
Day's Low
1,643.50p
Volume
4,642,219
Avg. Vol
8,603,891
52-wk High
1,716.50p
52-wk Low
1,210.27p

Lewent, Judy 

Ms. Judy C. Lewent is Non-Executive Independent Director of Glaxosmithkline Plc., effective May 8, 2014. Judy has extensive knowledge of the global pharmaceutical industry and of corporate finance, having joined Merck & Co. in 1980 and then served as Chief Financial Officer from 1990 to 2007 when she retired. Judy was previously a Non-Executive Director of Purdue Pharma Inc, Napp Pharmaceutical Holdings Limited and certain Mundipharma International Limited companies until 31 December 2014. Judy previously served as a Non-Executive Director of Dell Inc. and Quaker Oats Company. The Board has determined that Judy has recent and relevant financial experience, and agreed that she has the appropriate qualifications and background to be an audit committee financial expert. External appointments Judy is a Non-Executive Director of Thermo Fisher Scientific Inc. and Motorola Solutions Inc. She is also a Trustee of the Rockefeller Family Trust and Chairperson of the Audit Committee of Rockefeller Financial Services, a life member of the Massachusetts Institute of Technology Corporation and a member of the American Academy of Arts and Sciences.

Basic Compensation

Total Annual Compensation, GBP 340,000
Restricted Stock Awards, GBP --
Long-Term Incentive Plans, GBP --
All Other, GBP 262,000
Fiscal Year Total, GBP 602,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --